Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11999)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 21, 2015 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ansari D, Gustafsson A, Andersson R. Update on the management of pancreatic cancer: Surgery is not enough. World J Gastroenterol 2015; 21(11): 3157-3165 [PMID: 25805920 DOI: 10.3748/wjg.v21.i11.3157] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v21/i11/3157.htm |
| Number | Citing Articles |
| 1 |
Roland Andersson, Caj Haglund, Hanna Seppänen, Daniel Ansari. Pancreatic cancer – the past, the present, and the future. Scandinavian Journal of Gastroenterology 2022; 57(10): 1169 doi: 10.1080/00365521.2022.2067786
|
| 2 |
Natalie K. Horvat, Isaac Karpovsky, Maggie Phillips, Megan M. Wyatt, Margaret A. Hall, Cameron J. Herting, Jacklyn Hammons, Zaid Mahdi, Richard A. Moffitt, Chrystal M. Paulos, Gregory B. Lesinski. Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy. Journal for ImmunoTherapy of Cancer 2024; 12(1): e008086 doi: 10.1136/jitc-2023-008086
|
| 3 |
Jan-Paul Gundlach, Charlotte Hauser, Franka Maria Schlegel, Christine Böger, Christian Röder, Christoph Röcken, Thomas Becker, Jan-Hendrik Egberts, Holger Kalthoff, Anna Trauzold. Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4688-8
|
| 4 |
Tzu-Pin Lu, Chien-Hui Wu, Chia-Chen Chang, Han-Ching Chan, Amrita Chattopadhyay, Wen-Chung Lee, Chun-Ju Chiang, Hsin-Ying Lee, Yu-Wen Tien. Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry. Annals of Surgical Oncology 2022; 29(3): 1608 doi: 10.1245/s10434-021-11030-w
|
| 5 |
Yves Vandenbrouck, David Christiany, Florence Combes, Valentin Loux, Virginie Brun. Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer. PROTEOMICS 2019; 19(21-22) doi: 10.1002/pmic.201800489
|
| 6 |
Anthony Filson, Robert C. G. Martin. Infection reporting in patients undergoing irreversible electroporation of locally advanced pancreatic cancer. Journal of Surgical Oncology 2023; 128(4): 531 doi: 10.1002/jso.27310
|
| 7 |
Hadi M.H. Diab, Henry G. Smith, Kristian K. Jensen, Lars N. Jørgensen. The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic review. European Journal of Cancer 2021; 154: 73 doi: 10.1016/j.ejca.2021.05.033
|
| 8 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. World Journal of Gastroenterology 2022; 28(48): 6827-6845 doi: 10.3748/wjg.v28.i48.6827
|
| 9 |
Vanaja Konduri, Sujith K. Joseph, Tiara T. Byrd, Zeid Nawas, Jonathan Vazquez-Perez, Colby J. Hofferek, Matthew M. Halpert, Dongliang Liu, Zhengdong Liang, Yunyu Baig, Vita S. Salsman, Damilola Oyewole-Said, Anna Tsimelzon, Briana A. Burns, Changyi Chen, Jonathan M. Levitt, Qizhi Yao, Nabil M. Ahmed, Meenakshi Hegde, William K. Decker. A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma. Science Translational Medicine 2021; 13(592) doi: 10.1126/scitranslmed.abc3196
|
| 10 |
Ulrike Heger, Claudia Mack, Christine Tjaden, Feng Pan, Thomas Pausch, Ulf Hinz, Christof M. Sommer, Thilo Hackert. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery. Pancreatology 2021; 21(7): 1349 doi: 10.1016/j.pan.2021.08.002
|
| 11 |
Feredun S. Azari, Charles M. Vollmer, Robert E. Roses, Luke Keele, Ronald P. DeMatteo, Jeffrey A. Drebin, Major Kenneth Lee. A contemporary analysis of palliative procedures in aborted pancreatoduodenectomy: Morbidity, mortality, and impact on future therapy. Surgery 2020; 168(6): 1026 doi: 10.1016/j.surg.2020.06.041
|
| 12 |
Michael J. Wright, Heidi N. Overton, Jonathan A. Teinor, Ding Ding, Richard A. Burkhart, John L. Cameron, Jin He, Christopher L. Wolfgang, Matthew J. Weiss, Ammar A. Javed. Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery 2020; 24(7): 1590 doi: 10.1007/s11605-019-04311-z
|
| 13 |
Liang Zhao, Hongru Kong, Hongwei Sun, Zongjing Chen, Bicheng Chen, Mengtao Zhou. LncRNA‐PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR‐448. Journal of Cellular Physiology 2018; 233(5): 4044 doi: 10.1002/jcp.26072
|
| 14 |
G. Balzano, P. Maffi, R. Nano, A. Mercalli, R. Melzi, F. Aleotti, A. Zerbi, F. De Cobelli, F. Gavazzi, P. Magistretti, M. Scavini, J. Peccatori, A. Secchi, F. Ciceri, A. Del Maschio, M. Falconi, L. Piemonti. Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis. American Journal of Transplantation 2016; 16(6): 1812 doi: 10.1111/ajt.13656
|
| 15 |
Beate Haugk, Shreya Raman. Pancreatic pathology: an update. Surgery (Oxford) 2016; 34(6): 273 doi: 10.1016/j.mpsur.2016.03.012
|
| 16 |
George Younan. Pancreas Solid Tumors. Surgical Clinics of North America 2020; 100(3): 565 doi: 10.1016/j.suc.2020.02.008
|
| 17 |
Myrna Hurtado, Laszlo Prokai, Umesh T. Sankpal, Blair Levesque, Rajasekhar Maram, Jaya Chhabra, Deondra T. Brown, Raj K. Gurung, Alvin A. Holder, Jamboor K. Vishwanatha, Riyaz Basha. Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cells. Process Biochemistry 2020; 89: 155 doi: 10.1016/j.procbio.2019.10.022
|
| 18 |
Oana Fufă, Roxana C. Popescu, Tudor G. Gherasim, Alexandru M. Grumezescu, Ecaterina Andronescu. Nanostructures for Cancer Therapy. 2017; : 405 doi: 10.1016/B978-0-323-46144-3.00016-7
|
| 19 |
M. Shahzad Ali, Kheshwant S. Gill, Giuseppe Saglio, Daniela Cilloni, Declan M. Soden, Patrick F. Forde. Expressional changes in stemness markers post electrochemotherapy in pancreatic cancer cells. Bioelectrochemistry 2018; 122: 84 doi: 10.1016/j.bioelechem.2018.03.009
|
| 20 |
Sally A. El-Zahaby, Yosra S.R. Elnaggar, Ossama Y. Abdallah. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art. Journal of Controlled Release 2019; 293: 21 doi: 10.1016/j.jconrel.2018.11.013
|
| 21 |
Tizong Miao, Alistair Symonds, Oliver J. Hickman, Dongsheng Wu, Ping Wang, Nick Lemoine, Yaohe Wang, Spiros Linardopoulos, Gunnel Halldén. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models. International Journal of Molecular Sciences 2024; 25(2): 1265 doi: 10.3390/ijms25021265
|
| 22 |
Zhi Zhang, Tao Yu, Wei Geng. Long non-coding RNA CCHE1 participates in postoperative distant recurrence but not local recurrence of osteosarcoma possibly by interacting with ROCK1. BMC Musculoskeletal Disorders 2020; 21(1) doi: 10.1186/s12891-020-3184-x
|
| 23 |
Ulrike Heger, Huihui Sun, Ulf Hinz, Ulla Klaiber, Masayuki Tanaka, Bing Liu, Milena Sachsenmaier, Christoph Springfeld, Christoph W. Michalski, Markus W. Büchler, Thilo Hackert. Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival. HPB 2020; 22(2): 224 doi: 10.1016/j.hpb.2019.06.012
|
| 24 |
Vivek K. Kashyap, Qinghui Wang, Saini Setua, Prashanth K. B. Nagesh, Neeraj Chauhan, Sonam Kumari, Pallabita Chowdhury, Duane D. Miller, Murali M. Yallapu, Wei Li, Meena Jaggi, Bilal Bin Hafeez, Subhash C. Chauhan. Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-018-1009-7
|
| 25 |
Jie Yang, Zhen Dong, Aishu Ren, Gang Fu, Kui Zhang, Changhong Li, Xiangwei Wang, Hongjuan Cui. Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down‐regulating CCNE2 in pancreatic ductal adenocarcinoma. Journal of Cellular and Molecular Medicine 2020; 24(7): 4245 doi: 10.1111/jcmm.15086
|
| 26 |
Alexander Arlt, Heiner Schäfer. Investigational histone deacetylase inhibitors for treating pancreatic adenocarcinoma. Expert Opinion on Investigational Drugs 2016; 25(11): 1251 doi: 10.1080/13543784.2016.1240167
|
| 27 |
Astrid Belalcazar, Olatunji B. Alese. Current and Emerging Therapies in Pancreatic Cancer. 2018; : 361 doi: 10.1007/978-3-319-58256-6_20
|
| 28 |
Chung-Tzu Hsueh, Julie H Selim, James Y Tsai, Chung-Tsen Hsueh. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. World Journal of Gastroenterology 2016; 22(31): 7080-7090 doi: 10.3748/wjg.v22.i31.7080
|
| 29 |
Jinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa, Jorrit De Waele, Jonas Van Audenaerde, Elly Marcq, Julie Jacobs, Abraham Lin, Eva Lion, Heleen Dewitte, Marc Peeters, Sylvia Dewilde, Filip Lardon, Annemie Bogaerts, Christophe Deben, Evelien Smits. Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells. Cancers 2019; 11(10): 1597 doi: 10.3390/cancers11101597
|
| 30 |
Khan Mohammad Imran, Margaret A. Nagai-Singer, Rebecca M. Brock, Nastaran Alinezhadbalalami, Rafael V. Davalos, Irving Coy Allen. Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.853779
|
| 31 |
Can Yurttas, Philipp Horvath, Imma Fischer, Christoph Meisner, Silvio Nadalin, Ingmar Königsrainer, Alfred Königsrainer, Stefan Beckert, Markus W. Löffler. A Prospective, Phase I/II, Open-Label Pilot Trial to Assess the Safety of Hyperthermic Intraperitoneal Chemotherapy After Oncological Resection of Pancreatic Adenocarcinoma. Annals of Surgical Oncology 2021; doi: 10.1245/s10434-021-10187-8
|
| 32 |
Dongming Liu, Tianqiang Song. Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China. BioScience Trends 2021; 15(3): 142 doi: 10.5582/bst.2021.01083
|
| 33 |
Loveena Sreedharan, Bhaskar Kumar, Anna Jewell, Paul Banim, Andreas Koulouris, Andrew R Hart. Bridging clinic: The initial medical management of patients with newly diagnosed pancreatic cancer. Frontline Gastroenterology 2019; 10(3): 261 doi: 10.1136/flgastro-2018-101002
|
| 34 |
Min Xuan, Na Li, Chunyan Wu. A meta-analysis on the efficacy of endoscopic ultrasonography for treatment of pancreatic cancer. Clinics 2024; 79: 100348 doi: 10.1016/j.clinsp.2024.100348
|
| 35 |
Beate Haugk, Shreya Raman, Yvonne Bury. Pancreatic pathology: where are we in 2019?. Surgery (Oxford) 2019; 37(6): 310 doi: 10.1016/j.mpsur.2019.03.003
|
| 36 |
Heléne Lindholm, Katarina Ejeskär, Ferenc Szekeres. Digitoxin Affects Metabolism, ROS Production and Proliferation in Pancreatic Cancer Cells Differently Depending on the Cell Phenotype. International Journal of Molecular Sciences 2022; 23(15): 8237 doi: 10.3390/ijms23158237
|
| 37 |
Hussein H. Khachfe, Abdulrahman Y. Hammad, Samer AlMasri, Ibrahim Nassour, Rudy ElAsmar, Hao Liu, Annissa de Silva, Jasmine Kraftician, Kenneth K. Lee, Amer H. Zureikat, Alessandro Paniccia. Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology 2024; 129(6): 1097 doi: 10.1002/jso.27595
|
| 38 |
A. A. Shabunin, A. A. Karpov, E. V. Kizhaev, V. V. Bedin, M. M. Tavobilov, O. V. Paklina, G. R. Setdikova. Combined surgical treatment of pancreatic head cancer. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2018; 23(3): 8 doi: 10.16931/1995-5464.201838-13
|
| 39 |
Gyulnara G. Kasumova, Mariam F. Eskander, Susanna W.L. de Geus, Mario Matiotti Neto, Omidreza Tabatabaie, Sing Chau Ng, Rebecca A. Miksad, Anand Mahadevan, James R. Rodrigue, Jennifer F. Tseng. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy. Surgery 2017; 162(2): 275 doi: 10.1016/j.surg.2017.03.009
|
| 40 |
Liu Qu, Zhao Zhiming, Tan Xianglong, Gao Yuanxing, Xu Yong, Liu Rong, Lau Wan Yee. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study. International Journal of Surgery 2018; 55: 81 doi: 10.1016/j.ijsu.2018.05.024
|
| 41 |
Angelo Wilson. The Molecular Connections between Lung and Pancreatic Cancer Metastases: are we not seeing the Forest for the Trees?. Journal of Cancer Prevention & Current Research 2017; 7(4) doi: 10.15406/jcpcr.2017.07.00242
|
| 42 |
Masaki Morimoto, Yosuke Horikoshi, Kazuhiro Nakaso, Tatsuyuki Kurashiki, Yoshinori Kitagawa, Takehiko Hanaki, Teruhisa Sakamoto, Soichiro Honjo, Yoshihisa Umekita, Yoshiyuki Fujiwara, Tatsuya Matsura. Oncogenic role of TYRO3 receptor tyrosine kinase in the progression of pancreatic cancer. Cancer Letters 2020; 470: 149 doi: 10.1016/j.canlet.2019.11.028
|
| 43 |
Kartz Bibb, Ritikraj Arya, Sabita N. Saldanha. Epigenetic Mechanisms in Cancer. 2018; : 345 doi: 10.1016/B978-0-12-809552-2.00013-9
|
| 44 |
Aditi Kothari, Matthew J. Flick. Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2021; 22(10): 5138 doi: 10.3390/ijms22105138
|
| 45 |
Ross A. Abrams, Kathryn A. Winter, Howard Safran, Karyn A. Goodman, William F. Regine, Adam C. Berger, Michael T. Gillin, Philip A. Philip, Andrew M. Lowy, Abraham Wu, Thomas A. DiPetrillo, Benjamin W. Corn, Samantha A. Seaward, Michael G. Haddock, Suisui Song, Yixing Jiang, Barbara J. Fisher, Alan W. Katz, Sharmila Mehta, Christopher G. Willett, Christopher H. Crane. Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head. American Journal of Clinical Oncology 2020; 43(3): 173 doi: 10.1097/COC.0000000000000633
|
| 46 |
Bhavik N. Patel, Eric W. Olcott, R. Brooke Jeffrey. Duodenal invasion by pancreatic adenocarcinoma: MDCT diagnosis of an aggressive imaging phenotype and its clinical implications. Abdominal Radiology 2018; 43(2): 332 doi: 10.1007/s00261-017-1271-8
|
| 47 |
Chang Moo Kang, BoKyeong Yun, Minju Kim, Mina Song, Yeon-hee Kim, Sung Hwan Lee, Hosun Lee, Song Mi Lee, Seung-Min Lee. Postoperative serum metabolites of patients on a low carbohydrate ketogenic diet after pancreatectomy for pancreatobiliary cancer: a nontargeted metabolomics pilot study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53287-y
|
| 48 |
Ulrike Erb, Margot Zöller. Progress and potential of exosome analysis for early pancreatic cancer detection. Expert Review of Molecular Diagnostics 2016; 16(7): 757 doi: 10.1080/14737159.2016.1187563
|
| 49 |
Maria Celeste Palmarocchi, Ruben Carlo Balzarotti Canger, Piercarlo Saletti. Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report. Oncology Letters 2017; 13(6): 4445 doi: 10.3892/ol.2017.6026
|
| 50 |
Claire M. Robinson, Aaron Talty, Susan E. Logue, Katarzyna Mnich, Adrienne M. Gorman, Afshin Samali. An Emerging Role for the Unfolded Protein Response in Pancreatic Cancer. Cancers 2021; 13(2): 261 doi: 10.3390/cancers13020261
|
| 51 |
Yalçın ERZURUMLU. Katlanmamış Protein Yanıtı Sinyal Yolunun IRE1α Kolunun Baskılanmasının PANC-1 Pankreatik Duktal Adenokarsinoma Hücrelerinin Tümörijenik Özellikleri Üzerindeki Etkilerinin İncelenmesi. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi 2022; 13(1): 11 doi: 10.22312/sdusbed.1003140
|
| 52 |
Bhavik N. Patel, Rajan T. Gupta, Sabino Zani, R. Brooke Jeffrey, Erik K. Paulson, Rendon C. Nelson. How the radiologist can add value in the evaluation of the pre- and post-surgical pancreas. Abdominal Imaging 2015; 40(8): 2932 doi: 10.1007/s00261-015-0549-y
|
| 53 |
Yuan Yu, Lei Liu, Ruirui Ma, Haibing Gong, Ping Xu, Congjun Wang. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer. Tumor Biology 2016; 37(10): 14249 doi: 10.1007/s13277-016-5270-0
|
| 54 |
Jie Hou, Zhan Wang, Hong Li, Hongzhi Zhang, Lan Luo. Gene Signature and Identification of Clinical Trait-Related m6 A Regulators in Pancreatic Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00522
|
| 55 |
Li-Lian Gan, Ling-Wei Hii, Shew-Fung Wong, Chee-Onn Leong, Chun-Wai Mai. Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion. Cancers 2020; 12(7): 1872 doi: 10.3390/cancers12071872
|
| 56 |
Neha Parveen, Afsana Sheikh, Mohammed A.S. Abourehab, Ritu Karwasra, Surender Singh, Prashant Kesharwani. Self-nanoemulsifying drug delivery system for pancreatic cancer. European Polymer Journal 2023; 190: 111993 doi: 10.1016/j.eurpolymj.2023.111993
|
| 57 |
Simone Donati, Cinzia Aurilia, Gaia Palmini, Irene Falsetti, Teresa Iantomasi, Maria Luisa Brandi. Autophagy-Related ncRNAs in Pancreatic Cancer. Pharmaceuticals 2022; 15(12): 1547 doi: 10.3390/ph15121547
|
| 58 |
Sathyan Nagendram, Satyajit Bhattacharya. Pancreatic cancer: a glimmer of hope. Trends in Urology & Men's Health 2023; 14(2): 5 doi: 10.1002/tre.904
|
| 59 |
Sarah Heiler, Zhe Wang, Margot Zöller. Pancreatic cancer stem cell markers and exosomes - the incentive push. World Journal of Gastroenterology 2016; 22(26): 5971-6007 doi: 10.3748/wjg.v22.i26.5971
|
| 60 |
John R. Bergquist, Cornelius A. Thiels, Christopher R. Shubert, Tommy Ivanics, Elizabeth B. Habermann, Santhi S. Vege, Travis E. Grotz, Sean P. Cleary, Rory L. Smoot, Michael L. Kendrick, David M. Nagorney, Mark J. Truty. Perception versus reality: A National Cohort Analysis of the surgery‐first approach for resectable pancreatic cancer. Cancer Medicine 2021; 10(17): 5925 doi: 10.1002/cam4.4144
|
| 61 |
Sultan Abdullah Alomari, Ahmed Sami Alfaqihi, Khalid Abdullah Alzahrani, Khalid Hassan Alzahrani, Khalid Mohammed Alzahrani, Khalid Abdulrahman Alzahrani, Abdulrahman Ahmed Asiri, Amjad Ali Durayb, Abdulaziz Marzouq Aloatibi, Mohammed Bassam Ghandourah. An Overview on the Role of Surgery in Resectable Pancreatic Tumors, Literature Review. Pharmacophore 2021; 12(4): 86 doi: 10.51847/RxWepx87LV
|
| 62 |
Jiqiao Zhu, Xianliang Li, Han Li, Zixi Liu, Jun Ma, Jiantao Kou, Qiang He. Enhanced recovery after surgery pathways benefit patients with soft pancreatic texture following pancreaticoduodenectomy. The American Journal of Surgery 2020; 219(6): 1019 doi: 10.1016/j.amjsurg.2019.08.002
|
| 63 |
Rachel A. High, Edward A. Randtke, Kyle M. Jones, Leila R. Lindeman, Jacqueline C. Ma, Shu Zhang, Lucia G. LeRoux, Mark D. Pagel. Extracellular acidosis differentiates pancreatitis and pancreatic cancer in mouse models using acidoCEST MRI. Neoplasia 2019; 21(11): 1085 doi: 10.1016/j.neo.2019.09.004
|
| 64 |
Huaibin Mabel Ko, Runjan Chetty. Pancreatic pathology for the surgeon. Surgery (Oxford) 2022; 40(4): 227 doi: 10.1016/j.mpsur.2022.01.003
|
| 65 |
Masanori Oshi, Stephanie Newman, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo, Matthew H. G. Katz, Kazuaki Takabe. High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection. Cancers 2020; 12(10): 2871 doi: 10.3390/cancers12102871
|
| 66 |
Maen Abdelrahim, Madeline J. Nash, Sriharika Gottipolu, Ala Abudayyeh, Riyaz Basha. Theranostic Approach for Pancreatic Cancer. 2019; : 195 doi: 10.1016/B978-0-12-819457-7.00010-4
|
| 67 |
Jana Enderes, Jessica Teschke, Martin von Websky, Steffen Manekeller, Jörg C. Kalff, Tim R. Glowka. Active smokers show ameliorated delayed gastric emptying after pancreatoduodenectomy. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01311-2
|
| 68 |
Hsiang-Lin Lee, Cheng-Ming Peng, Cheng-Yu Huang, Shin-Yi Wu, Ming-Chang Tsai, Chi-Chih Wang, Sung-Lang Chen, Chun-Che Lin, Chien-Ning Huang, Wen-Wei Sung. Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries. BMJ Open 2018; 8(7): e020618 doi: 10.1136/bmjopen-2017-020618
|
| 69 |
Valerie Zimmermann, Leonie Frauenfeld, Markus W. Löffler, André L. Mihaljevic, Can Yurttas. Long-term recurrence-free survival following pancreatic surgery with HIPEC treatment for locally advanced pancreatic adenocarcinoma. BMJ Case Reports 2024; 17(2): e258626 doi: 10.1136/bcr-2023-258626
|
| 70 |
Shufang Yang, Jie Liu, Haiying Jin, Xiang He, Peng Nie, Changfu Wang. Value of magnetic resonance images in preoperative staging and resectability assessment of pancreatic cancer. Journal of Cancer Research and Therapeutics 2018; 14(1): 155 doi: 10.4103/jcrt.JCRT_590_17
|
| 71 |
Han Yan, Wanglong Qiu, Anne K. Koehne de Gonzalez, Ji-Shu Wei, Min Tu, Chun-Hua Xi, Ye-Ran Yang, Yun-Peng Peng, Wei-Yann Tsai, Helen E. Remotti, Yi Miao, Gloria H. Su. HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Cancer Letters 2019; 442: 333 doi: 10.1016/j.canlet.2018.11.007
|
| 72 |
Wei Ge, Lei Wang, Jiayao Zhang, Changjin Ou, Weili Si, Wenjun Wang, Qingming Zhang, Xiaochen Dong. Self‐Assembled Nanoparticles as Cancer Therapeutic Agents. Advanced Materials Interfaces 2021; 8(1) doi: 10.1002/admi.202001602
|
| 73 |
M. I. Airapetov, S. O. Eresko, A. A. Lebedev, E. R. Bychkov, P. D. Shabanov. Expression of Ghrelin Receptor GHS-R1a in the Brain (Mini Review). Molecular Biology 2021; 55(4): 501 doi: 10.1134/S002689332103002X
|
| 74 |
Linjia Peng, Hao Chen. A novel nomogram and risk classification system based on inflammatory and immune indicators for predicting prognosis of pancreatic cancer patients with liver metastases. Cancer Medicine 2023; 12(18): 18622 doi: 10.1002/cam4.6471
|
| 75 |
Somala Mohammed, Sujita Sukumaran, Pradip Bajgain, Norihiro Watanabe, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, William E. Fisher, Ann M. Leen, Juan F. Vera. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer. Molecular Therapy 2017; 25(1): 249 doi: 10.1016/j.ymthe.2016.10.016
|
| 76 |
Sabya Sachi Das, Amit Kumar Dubey, Neeru Singh, Priya Ranjan Prasad Verma, Shubhankar Kumar Singh, Sandeep Kumar Singh. Hormone Related Cancer Mechanistic and Nanomedicines. 2022; : 149 doi: 10.1007/978-981-19-5558-7_8
|
| 77 |
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, Barbara Parrino, Stella Cascioferro, Patrizia Diana, Elisa Giovannetti, Daniela Carbone. Exploring the therapeutic potential of focal adhesion kinase inhibition in overcoming chemoresistance in pancreatic ductal adenocarcinoma. Future Medicinal Chemistry 2024; 16(3): 271 doi: 10.4155/fmc-2023-0234
|
| 78 |
Philip Sutera, Mark E. Bernard, Hong Wang, Nathan Bahary, Steven Burton, Herbert Zeh, Dwight E. Heron. Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00052
|
| 79 |
Cameron J. Herting, Isaac Karpovsky, Gregory B. Lesinski. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions. Cancer and Metastasis Reviews 2021; 40(3): 675 doi: 10.1007/s10555-021-09988-w
|
| 80 |
Cody C. Rounds, Sanzida Haque, Chengyue Li, Devin Nissen, Dhruv Ranjan, Marcella Vaicik, Rama S. Madhurapantula, Thomas C. Irving, Kenneth M. Tichauer, Conor L. Evans, Kin Foong Chan. Higher density of ECM composition in pancreatic cancer correlates with reduced drug delivery. Visualizing and Quantifying Drug Distribution in Tissue VII 2023; : 10 doi: 10.1117/12.2650840
|
| 81 |
Yu Zhang, Yueying Su, Yabing Zhao, Guoqiang Lv, Ying Luo. MicroRNA-720 inhibits pancreatic cancer cell proliferation and invasion by directly targeting cyclin D1. Molecular Medicine Reports 2017; 16(6): 9256 doi: 10.3892/mmr.2017.7732
|
| 82 |
Jing Zhou, Yuexu Jiang, Yue Huang, Qiongling Wang, Jussuf T. Kaifi, Eric T. Kimchi, Chiswili Yves Chabu, Zhenguo Liu, Trupti Joshi, Guangfu Li. Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy. Translational Oncology 2022; 15(1): 101262 doi: 10.1016/j.tranon.2021.101262
|
| 83 |
Philip Anthony Sutera, Mark E. Bernard, Beant S. Gill, Kamran K. Harper, Kimmen Quan, Nathan Bahary, Steven A. Burton, Herbert Zeh, Dwight E. Heron. One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review. Frontiers in Oncology 2017; 7 doi: 10.3389/fonc.2017.00272
|
| 84 |
Nikhil Tyagi, Saravanakumar Marimuthu, Arun Bhardwaj, Sachin K. Deshmukh, Sanjeev K. Srivastava, Ajay P. Singh, Steven McClellan, James E. Carter, Seema Singh. p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling. Cancer Letters 2016; 370(2): 260 doi: 10.1016/j.canlet.2015.10.028
|
| 85 |
Kexin Li, Qingji Huo, Kazumasa Minami, Keisuke Tamari, Kazuhiko Ogawa, Sungsoo Na, Melissa L. Fishel, Bai-Yan Li, Hiroki Yokota. Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(20): 4917 doi: 10.3390/cancers15204917
|
| 86 |
Panagiotis Sarantis, Evangelos Koustas, Adriana Papadimitropoulou, Athanasios G Papavassiliou, Michalis V Karamouzis. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World Journal of Gastrointestinal Oncology 2020; 12(2): 173-181 doi: 10.4251/wjgo.v12.i2.173
|
| 87 |
Luis Secanella, Juli Busquets, Núria Peláez, María Sorribas, Berta Laquente, Sandra Ruiz, Thiago Carnaval, Sebastián Videla, Juan Fabregat. Predictive factors for resection and survival in type A borderline resectable pancreatic ductal adenocarcinoma patients after neoadjuvant therapy: A retrospective cohort study. Medicine 2022; 101(48): e32126 doi: 10.1097/MD.0000000000032126
|
| 88 |
Nicola Silvestris, Oronzo Brunetti, Enrico Vasile, Francesco Cellini, Ivana Cataldo, Valeria Pusceddu, Monica Cattaneo, Stefano Partelli, Mario Scartozzi, Giuseppe Aprile, Andrea Casadei Gardini, Alessio Giuseppe Morganti, Vincenzo Valentini, Aldo Scarpa, Massimo Falconi, Angela Calabrese, Vito Lorusso, Michele Reni, Stefano Cascinu. Multimodal treatment of resectable pancreatic ductal adenocarcinoma. Critical Reviews in Oncology/Hematology 2017; 111: 152 doi: 10.1016/j.critrevonc.2017.01.015
|
| 89 |
Morsal Samim, Timothy H. Mungroop, Mohammed AbuHilal, Cas J. Isfordink, Quintus I. Molenaar, Marcel J. van der Poel, Thomas A. Armstrong, Arjun S. Takhar, Neil W. Pearce, John N. Primrose, Scott Harris, Helena M. Verkooijen, Thomas M. van Gulik, Jeroen Hagendoorn, Olivier R. Busch, Colin D. Johnson, Marc G. Besselink. Surgeons' assessment versus risk models for predicting complications of hepato-pancreato-biliary surgery (HPB-RISC): a multicenter prospective cohort study. HPB 2018; 20(9): 809 doi: 10.1016/j.hpb.2018.02.635
|
| 90 |
Alexander Ioannis Damanakis, Florian Gebauer, Felix Popp, Christiane Bruns. Textbook of Pancreatic Cancer. 2021; : 189 doi: 10.1007/978-3-030-53786-9_14
|
| 91 |
Marat I. Airapetov, Sergei O. Eresko, Andrei A. Lebedev, Evgenii R. Bychkov, Petr D. Shabanov. Expression of the growth hormone secretagogue receptor 1a (GHS‐R1a) in the brain. Physiological Reports 2021; 9(21) doi: 10.14814/phy2.15113
|
| 92 |
Jiqiao Zhu, Xianliang Li, Jiantao Kou, Jun Ma, Lixin Li, Hua Fan, Ren Lang, Qiang He. Proposed Chaoyang vascular classification for superior mesenteric-portal vein invasion, resection, and reconstruction in patients with pancreatic head cancer during pancreaticoduodenectomy – A retrospective cohort study. International Journal of Surgery 2018; 53: 292 doi: 10.1016/j.ijsu.2018.04.011
|
| 93 |
Ricardo Titze-de-Almeida, Catherine David, Simoneide Souza Titze-de-Almeida. The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market. Pharmaceutical Research 2017; 34(7): 1339 doi: 10.1007/s11095-017-2134-2
|
| 94 |
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochemical and Biophysical Research Communications 2018; 501(1): 313 doi: 10.1016/j.bbrc.2018.05.024
|
| 95 |
Jinping Zhang, Shuman Zhang, Isabella Dörflein, Xiaofan Ren, Susanne Pfeffer, Nathalie Britzen-Laurent, Robert Grützmann, Xianglong Duan, Christian Pilarsky. Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer. Cancers 2023; 15(19): 4842 doi: 10.3390/cancers15194842
|
| 96 |
Marwa Alhothali, Mevin Mathew, Geeta Iyer, Harshani R. Lawrence, Shengyu Yang, Srikumar Chellappan, Jaya Padmanabhan. Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC. International Journal of Molecular Sciences 2019; 20(10): 2423 doi: 10.3390/ijms20102423
|
| 97 |
Marika Franczak, Barbara Kutryb-Zajac, Btissame El Hassouni, Elisa Giovannetti, Carlotta Granchi, Filippo Minutolo, Ryszard T. Smolenski, Godefridus J. Peters. The effect of lactate dehydrogenase-A inhibition on intracellular nucleotides and mitochondrial respiration in pancreatic cancer cells. Nucleosides, Nucleotides & Nucleic Acids 2022; 41(12): 1375 doi: 10.1080/15257770.2022.2031215
|
| 98 |
Chang-Sup Lim, Kyongok Im, Dong Soon Lee, Wooil Kwon, Jae Ri Kim, Youngmin Han, Sun-Whe Kim, Jin-Young Jang. The Implication of Cytogenetic Alterations in Pancreatic Ductal Adenocarcinoma and Intraductal Papillary Mucinous Neoplasm Identified by Fluorescence In Situ Hybridization and Their Potential Diagnostic Utility. Gut and Liver 2020; 14(4): 509 doi: 10.5009/gnl19087
|
| 99 |
Tao Cheng, Zhiheng Zhang, Hua Shen, Ziying Jian, Junsheng Li, Yujun Chen, Yi Shen, Xinyi Dai. Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS production and endoplasmic reticulum stress mediated apoptosis. Journal of Nanobiotechnology 2020; 18(1) doi: 10.1186/s12951-020-00687-2
|
| 100 |
Masaya Jimbo, Fernando F. Blanco, Yu-Hung Huang, Aristeidis G. Telonis, Brad A. Screnci, Gabriela L. Cosma, Vitali Alexeev, Gregory E. Gonye, Charles J. Yeo, Janet A. Sawicki, Jordan M. Winter, Jonathan R. Brody. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget 2015; 6(29): 27312 doi: 10.18632/oncotarget.4743
|
| 101 |
Xinyang Huang, Liangchao Zhao, Yixun Jin, Zhuoxin Wang, Tong Li, Hui Xu, Qi Wang, Lifu Wang. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.827051
|
| 102 |
Felix Wiesmueller, Josephin Kopke, Daniela Aust, Janine Roy, Andreas Dahl, Christian Pilarsky, Robert Grützmann. Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer. International Journal of Molecular Sciences 2019; 20(21): 5437 doi: 10.3390/ijms20215437
|
| 103 |
Jiacheng Huang, Zhitao Chen, Chenchen Ding, Shengzhang Lin, Dalong Wan, Kuiwu Ren. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.711402
|
| 104 |
Hao Wu, Yin Zhang, Jiawei Liang, Jianzhuang Wu, Yixuan Zhang, Haochen Su, Qiyue Zhang, Yonghua Shen, Shanshan Shen, Lei Wang, Xiaoping Zou, Cheng Hang, Shu Zhang, Ying Lv. Lithium chloride induces apoptosis by activating endoplasmic reticulum stress in pancreatic cancer. Translational Oncology 2023; 38: 101792 doi: 10.1016/j.tranon.2023.101792
|
| 105 |
Gaurav Kumar, Mudassir Farooqui, Chinthalapally V. Rao. Role of Dietary Cancer-Preventive Phytochemicals in Pancreatic Cancer Stem Cells. Current Pharmacology Reports 2018; 4(4): 326 doi: 10.1007/s40495-018-0145-2
|
| 106 |
Liang Xue, Yan Shen, Zhenglong Zhai, Shusen Zheng. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1. International Journal of Molecular Medicine 2020; doi: 10.3892/ijmm.2020.4561
|
| 107 |
Hussein H. Khachfe, Abdulrahman Y. Hammad, Samer AlMasri, Annissa deSilva, Jasmine Kraftician, Kenneth K. Lee, Amer H. Zureikat, Alessandro Paniccia. Obesity Is Associated With Increased Risk for Adverse Postoperative Outcomes After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma. Journal of Surgical Research 2023; 284: 164 doi: 10.1016/j.jss.2022.11.050
|
| 108 |
Hiroki Shimomura, Reona Okada, Takako Tanaka, Yuto Hozaka, Masumi Wada, Shogo Moriya, Tetsuya Idichi, Yoshiaki Kita, Hiroshi Kurahara, Takao Ohtsuka, Naohiko Seki. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis. International Journal of Molecular Sciences 2020; 21(18): 6459 doi: 10.3390/ijms21186459
|
| 109 |
Ting Zhan, Xiaoli Chen, Xia Tian, Zheng Han, Meng Liu, Yanli Zou, Shasha Huang, Aifang Chen, Xueting Cheng, Junsheng Deng, Jie Tan, Xiaodong Huang. MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L. Technology in Cancer Research & Treatment 2020; 19: 153303382094580 doi: 10.1177/1533033820945801
|
| 110 |
Naresh Kumar, Pankaj Attri, Sylvia Dewilde, Annemie Bogaerts. Inactivation of human pancreatic ductal adenocarcinoma with atmospheric plasma treated media and water: a comparative study. Journal of Physics D: Applied Physics 2018; 51(25): 255401 doi: 10.1088/1361-6463/aac571
|
| 111 |
Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting. Cells 2024; 13(7): 602 doi: 10.3390/cells13070602
|
| 112 |
Huang-bao Li, Jun Zhou, Fengqing Zhao, Jiayin Yu, Longsheng Xu. <p>Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer</p>. Cancer Management and Research 2020; : 5997 doi: 10.2147/CMAR.S251897
|
| 113 |
Masaki Morimoto, Soichiro Honjo, Teruhisa Sakamoto, Takuki Yagyu, Ei Uchinaka, Takehiko Hanaki, Joji Watanabe, Tomoyuki Matsunaga, Manabu Yamamoto, Yoji Fukumoto, Naruo Tokuyasu, Yoshiyuki Fujiwara. Prognostic Impact of Pre- and Post-operative P-CRP Levels in Pancreatic Cancer Patients. Yonago Acta Medica 2020; 63(1): 70 doi: 10.33160/yam.2020.02.011
|
| 114 |
Aurélie Prignon, Claire Provost, Faisal Alshoukr, Dominique Wendum, Anne Couvelard, Jacques Barbet, Patricia Forgez, Jean-Noël Talbot, Anne Gruaz-Guyon. Preclinical Evaluation of 68Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis. Molecular Pharmaceutics 2019; 16(6): 2776 doi: 10.1021/acs.molpharmaceut.9b00283
|
| 115 |
Yves Boucher, Jessica M. Posada, Sonu Subudhi, Ashwin S. Kumar, Spencer R. Rosario, Liqun Gu, Heena Kumra, Mari Mino-Kenudson, Nilesh P. Talele, Dan G. Duda, Dai Fukumura, Jennifer Y. Wo, Jeffrey W. Clark, David P. Ryan, Carlos Fernandez-Del Castillo, Theodore S. Hong, Mikael J. Pittet, Rakesh K. Jain. Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer. Clinical Cancer Research 2023; 29(8): 1605 doi: 10.1158/1078-0432.CCR-22-1630
|
| 116 |
K.R. Manu, Gurleen Kaur, Ananya Kar, Lopamudra Giri, Waleed H. Almalki, Neelima Gupta, Amirhossein Sahebkar, Prashant Kesharwani, Rambabu Dandela. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; : 419 doi: 10.1016/B978-0-443-19142-8.00007-3
|
| 117 |
Callum Baird Nattress, Gunnel Halldén. Advances in oncolytic adenovirus therapy for pancreatic cancer. Cancer Letters 2018; 434: 56 doi: 10.1016/j.canlet.2018.07.006
|
| 118 |
R. Araujo-Gutierrez, J. L. Van Eps, D. Kirui, N. S. Bryan, Y. Kang, J. B. Fleming, J. S. Fernandez-Moure. Enhancement of gemcitabine cytotoxicity in pancreatic adenocarcinoma through controlled release of nitric oxide. Biomedical Microdevices 2019; 21(1) doi: 10.1007/s10544-019-0375-z
|
| 119 |
Xin Chen, Herbert J. Zeh, Rui Kang, Guido Kroemer, Daolin Tang. Cell death in pancreatic cancer: from pathogenesis to therapy. Nature Reviews Gastroenterology & Hepatology 2021; 18(11): 804 doi: 10.1038/s41575-021-00486-6
|
| 120 |
Eunsung Jun, Song Cheol Kim, Chan Mi Lee, Juyun Oh, Song Lee, In Kyong Shim. Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12670-3
|
| 121 |
Khan Mohammad Imran, Rebecca M. Brock, Natalie Beitel-White, Manali Powar, Katie Orr, Kenneth N. Aycock, Nastaran Alinezhadbalalami, Zaid S. Salameh, Paige Eversole, Benjamin Tintera, Justin Markov Madanick, Alissa Hendricks-Wenger, Sheryl Coutermarsh-Ott, Rafael V. Davalos, Irving C. Allen. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1352821
|